Suzhou Institute of Biomedical Engineering develops 3D-printed cardiac patch
Researchers at the Suzhou Institute of Biomedical Engineering, Chinese Academy of Sciences, have developed a novel 3D-printed cardiac patch that can promote cardiac repair and regeneration.
The new cardiac patch is designed to be implanted onto damaged heart tissue, where it can deliver therapeutic cells and biomolecules to aid in the healing process. The patch is fabricated using a specialized 3D bioprinting technique that allows for precise control over the placement of cells and extracellular matrix components, mimicking the complex structure of native heart tissue.
This innovative approach addresses limitations of current treatments for heart disease, which often involve invasive surgeries or therapies with limited efficacy. The 3D-printed patch offers a minimally invasive option that can potentially improve cardiac function and reduce scar formation after a heart attack or other cardiac injury.
The research team utilized a combination of biocompatible materials and living cells to create the patch. The specific types of cells and biomaterials used are designed to encourage the integration of the patch with the host tissue and stimulate the regeneration of functional cardiac muscle. Early studies have shown promising results in animal models, demonstrating improved heart function and reduced infarct size.
Further research and clinical trials are planned to evaluate the safety and efficacy of this 3D-printed cardiac patch in human patients. The development represents a significant step forward in the application of additive manufacturing for regenerative medicine and cardiovascular therapies.
This development highlights the growing role of 3D printing in advanced biomedical applications. The ability to precisely construct complex biological structures like cardiac patches is crucial for regenerative medicine. Such advancements could lead to more effective treatments for heart disease, reducing the need for transplants and improving patient outcomes, and showcases AM's potential in creating patient-specific medical devices.
Edited by the news editor with AI and translated into English from the original report — please refer to the original source.